Why the exact lymphoma subtype changes what you are consenting to
Lymphoma is not one disease. The National Cancer Institute describes lymphoma as including Hodgkin and non-Hodgkin types, and notes that the exact diagnosis matters when treatment is discussed. That single point drives most of the consent questions below. A plan described to you as 'lymphoma treatment' is not specific enough to agree to, because the pathology report, the prior regimens and the recorded response to those regimens are what a receiving team uses to judge whether a proposed next step is even the right question.
This is why the first consent question is not about the hospital or the price. It is: which documents does this team need in order to review my next treatment step at all? If the answer is vague, you cannot yet know what you are agreeing to. Ask them to name the records, not to describe them generally.
A records-based review is a starting point, not a final decision. It can clarify what is missing and what the next clinical question is. It does not establish that a particular regimen is available, that you are eligible for a trial or transplant, or that the hospital will accept your case. Those are separate confirmations, and each one should be traceable to a named person or document before you consent.
The records a lymphoma review actually needs
Ask the team to list the specific documents required to review your next treatment step. In practice, lymphoma planning turns on two record groups: pathology and treatment response. The pathology group establishes the subtype. The response group shows how the disease behaved under previous regimens. Without both, a review is working from an incomplete picture, and any plan built on it carries assumptions you have not seen.
For pathology, ask whether they need the original biopsy report, the immunohistochemistry or molecular results that support the subtype, and whether they want the actual slides or blocks sent for their own pathology review. A pathology re-review is a distinct step from a clinical consultation, and it can change the framing of the case. Ask who performs it and what it costs, if anything.
For treatment response, ask which imaging and laboratory records they need, from which time points, and in what format. Ask whether they need the reports alone or the images themselves. Ask how the records should be sent and whether translated summaries are acceptable or whether source-language documents are required. These are administrative questions with clinical consequences: if the wrong version arrives, the review may be delayed or based on a summary rather than the primary record.
A practical checklist you can send to the team, and ask them to confirm or amend: the original pathology report and any molecular or immunohistochemistry results; the most recent imaging reports and, if requested, the images; blood counts and other laboratory results from defined time points; a list of previous regimens with dates and the recorded response to each; and a short summary of your current symptoms and any treatment you are receiving now. Ask them to mark which items are essential and which are optional for their review.
Questions about the proposed plan that consent should not skip
Once the records are in front of the team, the consent conversation should cover what the plan is, what it is not, and what happens if it does not work. Ask them to state the goal of the proposed next step in plain terms: is it intended as curative, as disease control, as a bridge to another treatment, or as preparation for a decision that has not yet been made? A plan whose goal is unclear is hard to consent to meaningfully.
Ask what alternatives were considered and why they were set aside for your case. Ask what the team would do if the proposed approach is not tolerated or does not produce the expected response. Ask what monitoring is required, how often, and where it would happen. If the plan involves admission, ask what triggers admission, how long it is expected to last, and what would need to be true for discharge. These are not challenges to the team's judgement; they are the information you need to weigh a decision.
Ask who is responsible for each part of the plan. In a complex case, more than one specialty may be involved. Ask which clinician leads the case, who reviews the pathology, who makes the final recommendation, and who you contact with questions between visits. If a multidisciplinary review is proposed, ask what it covers and what it does not. A review that produces a recommendation is not the same as a confirmed treatment slot.
Finally, ask what the team needs from you before they can move from review to a confirmed plan. A specific record, a repeat test, or a confirmed appointment may be what stands between a preliminary opinion and a decision you can act on.
What the written plan should state before you agree
Ask for the plan in writing, and ask what it includes, what it excludes, and what remains undecided. A written plan is easier to question than a verbal summary, and it gives you a record of what was actually proposed. If the team cannot provide a written version, ask them to confirm the key points in a message you can keep.
The written plan should identify the proposed treatment approach, the setting in which it would be given, the monitoring it requires, and the criteria the team would use to judge whether it is working. It should also state what would cause the plan to change. Ask specifically what is not included: for example, whether a particular test, medicine, or admission is part of the plan or would be arranged separately. If the answer is that something is undecided, ask what would resolve it and when.
Ask who pays for what, and to whom. Hospital charges, clinician fees, and any coordination or interpretation services are separate matters, and you should ask the specific provider for a written quote that states its scope. Do not assume that a quoted figure covers everything, and do not assume that a service you have not requested is included. If you are working with a coordinator, ask them to confirm in writing which charges are theirs and which are the hospital's.
Ask what happens if you decide not to proceed, or if you want a second opinion before consenting. A plan that cannot accommodate a reasonable pause for questions is a plan you should understand fully before agreeing to it.
Admission, monitoring and who decides suitability
Ask the treating hospital, not a coordinator, to confirm whether your case is suitable for the proposed plan and whether admission is required. Suitability is a clinical decision made by the hospital and its licensed clinicians. A records review, a preliminary reply, or an appointment request does not establish suitability, and it does not confirm that a bed, a slot, or a particular treatment is available.
If admission is part of the plan, ask what the admission is for, what monitoring happens during it, and what the discharge criteria are. Ask who supervises your care during admission and who you speak to if something changes. Ask what happens after discharge: what follow-up is arranged, where, and with whom. If the plan involves treatment that requires specific monitoring, ask how that monitoring is organised and what would prompt a change in approach.
Ask what the team would do if you became unwell before travelling or during the admission. Ask whether there are any restrictions on your current treatment while the review is underway. Do not stop or change any treatment you are receiving now on the basis of an overseas enquiry. If you have urgent or worsening symptoms, seek local care first; an overseas review can continue alongside that.
Ask who is accountable for the handover between your current team and the team in China. If records are being sent, ask who sends them, who receives them, and who confirms they arrived. A handover is not complete until the receiving clinician has the records and has confirmed what they will do with them. Ask for that confirmation in writing.
How to get clear answers before you consent
Put your questions in writing and ask for written answers. This is not a formality: it creates a record you can compare against what you are later told, and it makes vague answers visible. If a reply does not answer the question, ask again, more narrowly. 'Which pathology records do you need?' is easier to answer than 'what do you need from me?'
Ask the team to distinguish between what is confirmed and what is still a question. A confirmed appointment is different from a provisional clinical stage. A recommendation is different from an available treatment slot. A review is different from a decision. Ask them to label each item, and ask what would move an item from one category to the next.
If you are considering care in China, you can start with a short summary of your situation rather than a full medical archive. An initial enquiry is free and does not require buying a proxy consultation. The team can tell you what is missing and what the relevant next step is. You can share records after first contact, once you know what is actually needed.
A brief note on how ChinaSpecialistCare can help: we can request a specialist appointment, help with records and interpretation, and coordinate practical arrangements once a hospital has accepted your case. We do not decide suitability, prescribe, or promise that a treatment is available. You can begin with a short summary through the enquiry form, email, or WhatsApp, and share records after first contact.
Before you consent, you should be able to state, in your own words, what the proposed plan is, what it is for, what it does not include, who is responsible for each part, and what would cause it to change. If you cannot, the consent conversation is not finished.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.